Arvinas (ARVN) EBITDA (2017 - 2026)
Arvinas' (ARVN) quarterly EBITDA came in at -$63.8 million in Q1 2026, down 189.36% year-on-year from $71.4 million in Q1 2025, and up 14.48% quarter-over-quarter from -$74.6 million in Q4 2025.
Arvinas (ARVN) EBITDA (2017 - 2026) Analysis & Trends
Arvinas' EBITDA history runs 10 years deep, the most recent figure standing at -$63.8 million for Q1 2026.
- On a quarterly basis, EBITDA fell 189.36% year-over-year to -$63.8 million in Q1 2026; TTM through Mar 2026 was -$253.7 million, a 165.38% decrease from a year earlier, with the FY2025 full-year figure at -$118.5 million, up 52.64% from the prior year.
- EBITDA climbed to -$63.8 million in Q1 2026 per ARVN's latest filing, from -$74.6 million in the prior quarter.
- Across five years, EBITDA topped out at $71.4 million in Q1 2025 and bottomed at -$165.3 million in Q4 2023.
- The 5-year median for EBITDA is -$65.8 million (2022), against an average of -$64.6 million.
- Across the five-year window, EBITDA jumped 185.71% in 2025 and slumped 189.36% in 2026, its largest moves.
- Year by year, EBITDA stood at -$75.6 million in 2022, then slumped by 118.65% to -$165.3 million in 2023, then soared by 64.79% to -$58.2 million in 2024, then decreased by 28.18% to -$74.6 million in 2025, then advanced by 14.48% to -$63.8 million in 2026.
- Per Business Quant, the three latest ARVN EBITDA figures stand at -$63.8 million (Q1 2026), -$74.6 million (Q4 2025), and -$43.8 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | -63.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.80 Mn |
| Dec 31, 2025 | -74.60 Mn |
| Sep 30, 2025 | -43.80 Mn |
| Jun 30, 2025 | -71.50 Mn |
| Mar 31, 2025 | 71.40 Mn |
| Dec 31, 2024 | -58.20 Mn |
| Sep 30, 2024 | -60.30 Mn |
| Jun 30, 2024 | -48.50 Mn |
| Mar 31, 2024 | -83.30 Mn |
| Dec 31, 2023 | -165.30 Mn |
| Sep 30, 2023 | -73.90 Mn |
| Jun 30, 2023 | -74.60 Mn |
| Mar 31, 2023 | -87.70 Mn |
| Dec 31, 2022 | -75.60 Mn |
| Sep 30, 2022 | -64.30 Mn |
| Jun 30, 2022 | -65.80 Mn |
| Mar 31, 2022 | -57.70 Mn |
| Dec 31, 2021 | -47.50 Mn |
| Sep 30, 2021 | -47.30 Mn |
| Jun 30, 2021 | -51.90 Mn |